Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (8.000.000 €): MachinE Learning Ledger Orchestrierung für Drug DiscoverY Hor27.05.2019 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
MachinE Learning Ledger Orchestrierung für Drug DiscoverY
MELLODDY will demonstrate how the pharmaceutical industry can better leverage its data assets to virtualize the Drug Discovery (DD) process with world-leading Machine Learning (ML) technologies as an answer to the ever-increasing challenges and stricter regulatory requirements it is facing. The lack of a tested, secure and privacy-preserving platform for federated machine learning that enables pharmaceutical partners to extract DD-relevant information from all types of, not only their own but even each other’s competitive data, without mutual disclosure of the chemistry and biology each partner has worked on, has previously held back such demonstration, to the detriment of patients in the EU and beyond. MELLODDY’s ten pharmaceutical partners will enable this demonstration with an unprecedented volume of more than a billion highly private and competitive DD-relevant data points, and hundreds of Tbs of image data that annotate the biological effects of more than 10 million small molecules. The successful demonstration of the predictive benefits, i.e. increased predictive model performance and chemical applicability domain, of unlocking this data volume, while strictly preserving the privacy of all underlying data and the resulting predictive models, will shape best practices and translate into substantial efficiency gains in the DD process, and in the future, drug development. Finally, MELLODDY will prepare and exploit a service-for-fee vehicle to ensure the MELLODDY technologies are available to the rest of the pharmaceutical sector.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| AMGEN RESEARCH (MUNICH) GmbH | 0,00 € |
| Astellas Pharma Europe B.V. | 0,00 € |
| Astrazeneca AB | 0,00 € |
| BAYER AG | 0,00 € |
| 0,00 € | |
| 1.253.297 € | |
| 0,00 € | |
| Iktos | 343.402 € |
| Institut de Recherches Servier | 0,00 € |
| Janssen Pharmaceutica N.V. | 0,00 € |
| KUBERMATIC GmbH | 1.716.178 € |
| Katholieke Universiteit Leuven | 1.145.006 € |
| MERCK KGaA | 0,00 € |
| NOVARTIS PHARMA AG | 0,00 € |
| NVIDIA SWITZERLAND AG | 0,00 € |
| Owkin France | 2.683.635 € |
| Substra | 858.482 € |
Quelle: https://cordis.europa.eu/project/id/831472
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "AMGEN RESEARCH (MUNICH) GmbH - EU-Förderung (8.000.000 €): MachinE Learning Ledger Orchestrierung für Drug DiscoverY"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
